Skip to main content

Part of the book series: Biophysics for the Life Sciences ((BIOPHYS,volume 4))

  • 2094 Accesses

Abstract

This chapter serves as an introduction to the entire volume. A brief description of protein primary, secondary, and tertiary structure, as well as the importance of the appropriate folded structure for the safety and efficacy of protein pharmaceuticals, is presented. This is followed by an overview of the development life cycle for biotherapeutics, beginning with target identification, through candidate selection, process and formulation development, and commercialization.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Dobsen CM (2004) Principles of protein folding, misfolding, and aggregation. Semin Cell Dev Biol 15:3–16

    Article  Google Scholar 

  • Mahler H-C, Friess W, Grauschopf U, Kiese S (2009) Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 98:2909–2934

    Article  PubMed  CAS  Google Scholar 

  • Narhi LO, Jiang Y, Deshpande R, Kang S, Shultz J (2010) Approaches to control protein aggregation during bulk production. In: Wang W, Roberts CJ (eds) Aggregation of therapeutic proteins. Wiley, Hoboken

    Google Scholar 

  • Pavlou AK, Belsey MJ (2005) The therapeutic antibody market to 2008. Eur J Pharm Biopharm 59:389–396

    Article  PubMed  Google Scholar 

  • Walsh G (2010) Biopharmaceutical benchmarks. Nat Biotechnol 28:917–924

    Article  PubMed  CAS  Google Scholar 

  • Wang W, Singh S, Zeng DL, King K, Nema S (2007) Antibody structure, instability and formulation. J Pharm Sci 96:1–26

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Linda O. Narhi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Narhi, L.O. (2013). Introduction. In: Narhi, L. (eds) Biophysics for Therapeutic Protein Development. Biophysics for the Life Sciences, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4316-2_1

Download citation

Publish with us

Policies and ethics